How The Advanced Enzyme Technologies (NSEI:ADVENZYMES) Narrative Is Shifting Around A ₹370 Valuation
The fair value estimate for Advanced Enzyme Technologies has been kept steady at ₹370.0 per share, with no change in the headline price target despite refreshed model inputs. Bullish and bearish ...
ArcticZymes Technologies ASA (OSE: "AZT") today hosts its Capital Markets Day 2026 in Stockholm, outlining how the Company is ...
Discover the leading players and innovations shaping the global biosensors market with the "Biosensors Companies Quadrant" report by 360 Quadrants. This comprehensive industry analysis evaluates over ...
Gain, the go-to detergent known for spreading joy through long-lasting, irresistible scents is turning up the fragrance, freshness, and cleansing power with the introduction of Gain Plus—so consumers ...
Read more about AI-powered peptide discovery could transform fight against drug-resistant superbugs on Devdiscourse ...
Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life ...
Explore advances in protein imaging techniques and spatial proteomics. Learn how modern imaging tools reveal protein dynamics and organization in cells.
Plastic to possibilities ...
Ginkgo Bioworks' new Ginkgo Cloud Lab interface will let researchers transition their benchwork to Ginkgo’s autonomous lab ...
Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the award of an up ...
The Times of Israel on MSN
Israeli researchers find cannabis compounds could lead to 1st drug for fatty liver disease
As 1 out of every 3 adults worldwide suffers from the condition, Hebrew University scientists use non-psychoactive substances ...
Dermatologists and editors agree – these peptide serums give your skin a youthful glow.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results